Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 27 | $12,897,789 |
Sells | 235 | $31,547,064 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
15 Jun 2023 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Jun 2023 | Sale | 25,000 | 9.9323 | 248,308 | D |
15 Jun 2023 19:30 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 13 Jun 2023 | Sale | 15,485 | 9.9778 | 154,506 | D |
29 Jun 2023 17:57 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 27 Jun 2023 | Sale | 8,885 | 7.3876 | 65,639 | D |
03 Jul 2023 15:21 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 29 Jun 2023 | Sale | 3,000 | 7.49 | 22,470 | D |
13 Jul 2023 16:54 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 11 Jul 2023 | Sale | 8,885 | 6.8873 | 61,194 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 3,157 | 14.0821 | 44,457 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 13 Jul 2023 | Sale | 8,275 | 12.5852 | 104,143 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 3,195 | 13.1845 | 42,124 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 78,071 | 12.1465 | 948,289 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 24,302 | 11.2501 | 273,400 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 13 | 14.85 | 193 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 63 | 13.7541 | 867 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 127 | 12.3559 | 1,569 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 561 | 11.8245 | 6,634 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 550 | 14.0291 | 7,716 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 236 | 10.8698 | 2,565 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 4,693 | 12.4131 | 58,255 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 10,327 | 11.7442 | 121,282 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 4,430 | 10.8382 | 48,013 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 127 | 14.0601 | 1,786 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 850 | 12.4076 | 10,546 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 2,173 | 11.8005 | 25,642 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 850 | 10.8206 | 9,198 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 17,227 | 14.344 | 247,104 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,270 | 12.3873 | 40,506 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 7,898 | 11.7969 | 93,172 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,423 | 10.8658 | 37,194 | D |
19 Jul 2023 19:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 18 Jul 2023 | Sale | 30,000 | 13.74 | 412,200 | D |
19 Jul 2023 19:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 17 Jul 2023 | Sale | 30,000 | 11.72 | 351,600 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 9,859 | 15.999 | 157,734 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 13,150 | 15.3626 | 202,018 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 1,991 | 14.3626 | 28,596 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 18 Jul 2023 | Sale | 500 | 14.048 | 7,024 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 18 Jul 2023 | Sale | 24,500 | 13.6236 | 333,778 | D |
27 Jul 2023 18:30 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 25 Jul 2023 | Sale | 18,719 | 14.6089 | 273,464 | D |
27 Jul 2023 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 26 Jul 2023 | Sale | 20,000 | 14.41 | 288,200 | D |
27 Jul 2023 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 25 Jul 2023 | Sale | 20,000 | 14.3 | 286,000 | D |
28 Jul 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 27 Jul 2023 | Sale | 4,373 | 14.0461 | 61,424 | D |
28 Jul 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 27 Jul 2023 | Sale | 3,627 | 13.1155 | 47,570 | D |
04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 4,060 | 13.3631 | 54,254 | D |
04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 60,955 | 13.0171 | 793,457 | D |
10 Aug 2023 17:33 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 08 Aug 2023 | Sale | 3,272 | 11.7468 | 38,436 | D |
10 Aug 2023 17:33 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 08 Aug 2023 | Sale | 14,498 | 11.0255 | 159,848 | D |
17 Aug 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Aug 2023 | Sale | 25,000 | 8.9007 | 222,518 | D |
17 Aug 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Aug 2023 | Sale | 25,000 | 9.2717 | 231,792 | D |
17 Aug 2023 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Aug 2023 | Sale | 18,000 | 9.25 | 166,500 | D |
24 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 22 Aug 2023 | Sale | 8,885 | 8.9118 | 79,181 | D |
28 Aug 2023 18:04 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 24 Aug 2023 | Sale | 63 | 9.4532 | 596 | D |
28 Aug 2023 18:04 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 24 Aug 2023 | Sale | 2,937 | 8.639 | 25,373 | D |
07 Sep 2023 19:02 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 05 Sep 2023 | Sale | 8,885 | 8.7942 | 78,136 | D |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 1,000 | 8.8363 | 8,836 | I |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 20,000 | 8.8348 | 176,696 | I |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 4,000 | 8.8337 | 35,335 | I |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 33,765 | 8.7835 | 296,575 | D |
14 Sep 2023 18:26 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Sep 2023 | Sale | 25,000 | 8.6927 | 217,318 | D |
14 Sep 2023 18:26 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Sep 2023 | Sale | 25,000 | 8.4253 | 210,632 | D |
19 Sep 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Sep 2023 | Sale | 18,000 | 8.66 | 155,880 | D |
21 Sep 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 19 Sep 2023 | Sale | 8,885 | 8.3599 | 74,278 | D |
02 Oct 2023 18:19 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 28 Sep 2023 | Sale | 3,000 | 7.7198 | 23,159 | D |
05 Oct 2023 18:25 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 03 Oct 2023 | Sale | 8,885 | 7.2907 | 64,778 | D |
06 Oct 2023 18:12 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Oct 2023 | Sale | 59,794 | 7.2085 | 431,025 | D |
12 Oct 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 11 Oct 2023 | Sale | 25,000 | 6.8525 | 171,312 | D |
12 Oct 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 10 Oct 2023 | Sale | 25,000 | 7.0705 | 176,762 | D |
18 Oct 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Oct 2023 | Sale | 18,000 | 6.3 | 113,400 | D |
19 Oct 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 17 Oct 2023 | Sale | 8,885 | 6.5822 | 58,483 | D |
30 Oct 2023 18:26 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 26 Oct 2023 | Sale | 3,000 | 5.6283 | 16,885 | D |
02 Nov 2023 19:02 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 31 Oct 2023 | Sale | 8,885 | 5.2745 | 46,864 | D |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 1,000 | 5.137 | 5,137 | I |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 20,000 | 5.1147 | 102,294 | I |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 4,000 | 5.1411 | 20,564 | I |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 37,177 | 5.1996 | 193,306 | D |
16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Nov 2023 | Sale | 4,700 | 7.6168 | 35,799 | D |
16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Nov 2023 | Sale | 20,300 | 7.2506 | 147,187 | D |
16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Nov 2023 | Sale | 25,000 | 6.3177 | 157,942 | D |
16 Nov 2023 18:55 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 14 Nov 2023 | Sale | 8,885 | 6.3197 | 56,151 | D |
17 Nov 2023 17:52 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2023 | Sale | 18,000 | 6.51 | 117,180 | D |
17 Nov 2023 17:53 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 16 Nov 2023 | Sale | 3,000 | 6.7599 | 20,280 | D |
30 Nov 2023 17:41 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 28 Nov 2023 | Sale | 11,447 | 6.7195 | 76,918 | D |
08 Dec 2023 17:22 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Dec 2023 | Sale | 59,829 | 7.4946 | 448,394 | D |
14 Dec 2023 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 12 Dec 2023 | Sale | 11,447 | 7.3987 | 84,693 | D |
14 Dec 2023 18:53 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Dec 2023 | Sale | 25,000 | 7.5908 | 189,770 | D |
14 Dec 2023 18:53 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Dec 2023 | Sale | 25,000 | 7.3947 | 184,868 | D |
18 Dec 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | DAR ZAVAIN | Director | 14 Dec 2023 | Sale | 20,141 | 9 | 181,269 | D |
19 Dec 2023 19:22 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Dec 2023 | Sale | 18,000 | 9.6 | 172,800 | D |
28 Dec 2023 17:48 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 26 Dec 2023 | Sale | 20,054 | 10.6285 | 213,144 | D |
02 Jan 2024 16:58 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 28 Dec 2023 | Sale | 8,000 | 10.5817 | 84,654 | D |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 1,000 | 9.4939 | 9,494 | I |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 20,000 | 9.512 | 190,240 | I |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 4,000 | 9.5073 | 38,029 | I |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 30,853 | 9.4903 | 292,804 | D |
11 Jan 2024 18:50 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 09 Jan 2024 | Sale | 6,303 | 13.2124 | 83,278 | D |
11 Jan 2024 18:50 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 09 Jan 2024 | Sale | 13,751 | 13.8117 | 189,925 | D |
11 Jan 2024 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | LI DEAN Y | Director | 09 Jan 2024 | Sale | 28,038 | 13.65 | 382,719 | I |
11 Jan 2024 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | LI DEAN Y | Director | 09 Jan 2024 | Sale | 962 | 14.0282 | 13,495 | I |
18 Jan 2024 18:37 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 17 Jan 2024 | Sale | 25,000 | 10.2539 | 256,348 | D |
18 Jan 2024 18:37 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Jan 2024 | Sale | 25,000 | 10.4464 | 261,160 | D |
18 Jan 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Jan 2024 | Sale | 18,000 | 10.93 | 196,740 | D |
25 Jan 2024 18:13 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 23 Jan 2024 | Sale | 20,054 | 10.5756 | 212,083 | D |
29 Jan 2024 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 25 Jan 2024 | Sale | 8,000 | 10.3452 | 82,762 | D |
08 Feb 2024 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 06 Feb 2024 | Sale | 11,447 | 9.3028 | 106,489 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)